Cover Image

Stachyose Improves the Effects of Berberine on Glucose Metabolism by Regulating Intestinal Microbiota and Short-Chain Fatty Acids in Spontaneous Type 2 Diabetic KKAy Mice

Berberine (BBR) has the beneficial effects of anti-inflammation, anti-bacteria, and anti-diabetes. The clinical application of BBR has been hindered by its poor gastrointestinal absorption. Stachyose (Sta), a prebiotic agent, improves the composition of gut microbiota and benefits for diabetes. We t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hui Cao (Author), Caina Li (Author), Lei Lei (Author), Xing Wang (Author), Shuainan Liu (Author), Quan Liu (Author), Yi Huan (Author), Sujuan Sun (Author), Zhufang Shen (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The albumin-exendin-4 recombinant protein E2HSA improves glycemic control and β-cell function in spontaneous diabetic KKAy mice
by: Caina Li, et al.
Published: (2017)

Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice
by: Quan Liu, et al.
Published: (2021)

Anti-diabetic effects and mechanisms of action of a Chinese herbal medicine preparation JQ-R in vitro and in diabetic KKAy mice
by: Quan Liu, et al.
Published: (2017)

Effects of stachyose on gut microbiota and metabolic pathways in children with diarrhea
by: Bing WANG, et al.
Published: (2024)

The application of 2-NBDG as a fluorescent tracer for assessing hepatic glucose production in mice during hyperinsulinemic euglycemic clamp
by: Shuainan Liu, et al.
Published: (2012)

A cell-based fluorescent glucose transporter assay for SGLT2 inhibitor discovery
by: Yi Huan, et al.
Published: (2013)

Morus alba L. (Sangzhi) Alkaloids Promote Insulin Secretion, Restore Diabetic β-Cell Function by Preventing Dedifferentiation and Apoptosis
by: Lei Lei, et al.
Published: (2022)

Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice
by: Yang GN, et al.
Published: (2017)

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
by: Sa Yang, et al.
Published: (2022)

Modulation of Gut Microbiota and Metabolites by Berberine in Treating Mice With Disturbances in Glucose and Lipid Metabolism
by: Xinyi Fang, et al.
Published: (2022)

Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines
by: Wuwen Feng, et al.
Published: (2018)

Stachyose Alleviates Corticosterone-Induced Long-Term Potentiation Impairment via the Gut-Brain Axis
by: Yan Huang, et al.
Published: (2022)

Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins
by: Jinglong Liu, et al.
Published: (2014)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
by: Hu Li, et al.
Published: (2022)

Antibiotic-induced gut microbiota disruption promotes vascular calcification by reducing short-chain fatty acid acetate
by: Shi-Yu Zeng, et al.
Published: (2024)

Gut microbiota–derived short-chain fatty acids and kidney diseases
by: Li L, et al.
Published: (2017)

The Diagnostic Potential of Gut Microbiota-Derived Short-Chain Fatty Acids in Preeclampsia
by: Jialin Li, et al.
Published: (2022)

Gut microbiota and short‐chain fatty acid alterations in cachectic cancer patients
by: Jorne Ubachs, et al.
Published: (2021)

Gut microbiota as a target in the bone health of livestock and poultry: roles of short-chain fatty acids
by: Shu-Cheng Huang, et al.
Published: (2023)

Microbiota-Derived Short-Chain Fatty Acids: New Road in Colorectal Cancer Therapy
by: Sara Gomes, et al.
Published: (2022)

Baicalin circumvents anti-PD-1 resistance by regulating the gut microbiota metabolite short-chain fatty acids
by: Zhang Yu, et al.
Published: (2024)

Add-On Aliskiren Elicits Stronger Renoprotection Than High-Dose Valsartan in Type 2 Diabetic KKAy Mice That Do Not Respond to Low-Dose Valsartan
by: Bai Lei, et al.
Published: (2012)

Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes
by: Alessandra Puddu, et al.
Published: (2014)

Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE−/− Mice
by: Min Wu, et al.
Published: (2020)

Research progress of the relationship between berberine, oral microbiota and systemic diseases
by: GUO Fanyi, WANG Ruyu, DU Yifei, WANG Yuli, ZHOU Qigang
Published: (2024)

Effects of acupuncture on gut microbiota and short-chain fatty acids in patients with functional constipation: a randomized placebo-controlled trial
by: Xiang-Yun Yan, et al.
Published: (2023)

Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol
by: Lara R. Dugas, et al.
Published: (2018)

Berberine-microbiota interplay: orchestrating gut health through modulation of the gut microbiota and metabolic transformation into bioactive metabolites
by: Tessa Dehau, et al.
Published: (2023)

Transformation of berberine to its demethylated metabolites by the CYP51 enzyme in the gut microbiota
by: Zheng-Wei Zhang, et al.
Published: (2021)

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
by: Shengjie Yang, et al.
Published: (2021)

Short-Term Lincomycin Exposure Depletion of Murine Microbiota Affects Short-Chain Fatty Acids and Intestinal Morphology and Immunity
by: Shunfen Zhang, et al.
Published: (2020)

Are Nonnutritive Sweeteners Obesogenic? Associations between Diet, Faecal Microbiota, and Short-Chain Fatty Acids in Morbidly Obese Subjects
by: Per G. Farup, et al.
Published: (2019)

Unlocking a novel determinant of athletic performance: The role of the gut microbiota, short-chain fatty acids, and "biotics" in exercise
by: Kate M. Sales, et al.
Published: (2023)

Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors
by: Ilinca Suciu, et al.
Published: (2023)

Gut microbiota-derived short-chain fatty acids ameliorate methamphetamine-induced depression- and anxiety-like behaviors in a Sigmar-1 receptor-dependent manner
by: Kaikai Zhang, et al.
Published: (2023)

Shen-Bai-Jie-Du decoction suppresses the progression of colorectal adenoma to carcinoma through regulating gut microbiota and short-chain fatty acids
by: Min Huang, et al.
Published: (2024)

Kazak faecal microbiota transplantation induces short-chain fatty acids that promote glucagon-like peptide-1 secretion by regulating gut microbiota in db/db mice
by: Xue Han, et al.
Published: (2021)

Effects of Berberine on Atherosclerosis
by: Rui Rui, et al.
Published: (2021)

Exploring the Bidirectional Effects of Gut Microbiota and Short-Chain Fatty Acids on Urticaria Subtypes Through Mendelian Randomization and Mediation Analysis
by: Xiao X, et al.
Published: (2024)

Effect of Coptidis Rhizoma on gastrointestinal system before and after processing with wine based on gut microbiota and short chain fatty acids
by: Rui Tian, et al.
Published: (2024)